Unavy Acido Hialuronico 850 mg Recall
UNAVY ACIDO HIALURONICO, Conenido: 30 capletas de 850mg, distribuido por: EREN NATURAL S.A. DE C.V, Zappan, Jal. C.P, UPC 7 503046 054295
What is the FDA recall status?
The FDA record lists the status as Completed. This does not establish that a retained product is safe to consume or use. FDA enforcement data is not a live recall-lifecycle tracker. Check the agency notice or firm for current guidance.
Why was Unavy Acido Hialuronico 850 mg recalled?
Marketed without approved NDA/ANDA- Laboratory analysis found product to be tainted with undeclared ingredients: Dexamethasone, Diclofenac and Omeprazole.
What should I do if I have this product?
Follow the firm and FDA instructions for the affected product. Contact the recalling firm for current guidance.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare your product with the product description and available lot, UPC or model codes below from the official FDA record to check whether it is covered by this recall. If an identifier is missing or unclear, check the complete official notice or contact the firm; an incomplete match here does not establish that your product is unaffected.
Full product description
UNAVY ACIDO HIALURONICO, Conenido: 30 capletas de 850mg, distribuido por: EREN NATURAL S.A. DE C.V, Zappan, Jal. C.P, UPC 7 503046 054295
Which lot codes, UPCs or models are affected?
All Lots; All Expiration Dates.
- Agency record number
- D-0492-2025
- Product
- UNAVY ACIDO HIALURONICO, Conenido: 30 capletas de 850mg, distribuido por: EREN NATURAL S.A. DE C.V, Zappan, Jal. C.P, UPC 7 503046 054295
- Recalling firm
- Umary-USA.com
- Quantity
- 1,342 30-count bottles
- Distribution
- U.S. Nationwide via internet.
- Recall started
- May 21, 2025
- Report date
- June 25, 2025
- Classification
- Class I
- Status
- Completed
- Agency
- FDA (drug)